These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 26890751)

  • 1. Heterogeneous Language Profiles in Patients with Primary Progressive Aphasia due to Alzheimer's Disease.
    Louwersheimer E; Keulen MA; Steenwijk MD; Wattjes MP; Jiskoot LC; Vrenken H; Teunissen CE; van Berckel BN; van der Flier WM; Scheltens P; van Swieten JC; Pijnenburg YA
    J Alzheimers Dis; 2016; 51(2):581-90. PubMed ID: 26890751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF levels of Aβ1-38/Aβ1-40/Aβ1-42 and (11)C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease.
    Ikeda M; Tashiro Y; Takai E; Kurose S; Fugami N; Tsuda K; Arisaka Y; Kodaira S; Fujita Y; Makioka K; Mizuno Y; Shimada H; Harigaya Y; Takatama M; Amari M; Yamazaki T; Yamaguchi H; Higuchi T; Okamoto K; Tsushima Y; Ikeda Y
    Amyloid; 2014 Dec; 21(4):238-45. PubMed ID: 25139672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common and divergent neural correlates of anomia in amnestic and logopenic presentations of Alzheimer's disease.
    Leyton CE; Hodges JR; Piguet O; Ballard KJ
    Cortex; 2017 Jan; 86():45-54. PubMed ID: 27875715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology.
    Ramanan S; Flanagan E; Leyton CE; Villemagne VL; Rowe CC; Hodges JR; Hornberger M
    J Alzheimers Dis; 2016; 51(2):367-76. PubMed ID: 26890745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Word retrieval across the biomarker-confirmed Alzheimer's disease syndromic spectrum.
    Putcha D; Dickerson BC; Brickhouse M; Johnson KA; Sperling RA; Papp KV
    Neuropsychologia; 2020 Mar; 140():107391. PubMed ID: 32057937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Logopenic, mixed, or Alzheimer-related aphasia?
    Sajjadi SA; Patterson K; Nestor PJ
    Neurology; 2014 Apr; 82(13):1127-31. PubMed ID: 24574548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of anomia in non-semantic variants of primary progressive aphasia converge over time.
    Leyton CE; Landin-Romero R; Liang CT; Burrell JR; Kumfor F; Hodges JR; Piguet O
    Cortex; 2019 Nov; 120():201-211. PubMed ID: 31325799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological differentiation of progressive aphasic disorders.
    Harris JM; Saxon JA; Jones M; Snowden JS; Thompson JC
    J Neuropsychol; 2019 Jun; 13(2):214-239. PubMed ID: 29424041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and cortical trajectories in non-fluent primary progressive aphasia and Alzheimer's disease: A role for emotion processing.
    Landin-Romero R; Kumfor F; Ys Lee A; Leyton C; Piguet O
    Brain Res; 2024 Apr; 1829():148777. PubMed ID: 38286395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia.
    Giannini LAA; Irwin DJ; McMillan CT; Ash S; Rascovsky K; Wolk DA; Van Deerlin VM; Lee EB; Trojanowski JQ; Grossman M
    Neurology; 2017 Jun; 88(24):2276-2284. PubMed ID: 28515265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia.
    Mazzeo S; Polito C; Padiglioni S; Berti V; Bagnoli S; Lombardi G; Piaceri I; Carraro M; De Cristofaro MT; Passeri A; Ferrari C; Nacmias B; Sorbi S; Bessi V
    Neurobiol Aging; 2020 Dec; 96():155-164. PubMed ID: 33010672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid pet in primary progressive aphasia: case series and systematic review of the literature.
    Villarejo-Galende A; Llamas-Velasco S; Gómez-Grande A; Puertas-Martín V; Contador I; Sarandeses P; González-Sánchez M; Trincado R; Pilkington P; Ruiz-Solis S; Pérez-Martínez DA; Herrero-San Martín A
    J Neurol; 2017 Jan; 264(1):121-130. PubMed ID: 27815682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicoradiological and neuropathological evaluation of primary progressive aphasia.
    Shir D; Corriveau-Lecavalier N; Bermudez Noguera C; Barnard L; Pham NTT; Botha H; Duffy JR; Clark HM; Utianski RL; Knopman DS; Petersen RC; Boeve BF; Murray ME; Nguyen AT; Reichard RR; Dickson DW; Day GS; Kremers WK; Graff-Radford NR; Jones DT; Machulda MM; Fields JA; Whitwell JL; Josephs KA; Graff-Radford J
    J Neurol Neurosurg Psychiatry; 2024 Aug; 95(9):812-821. PubMed ID: 38514176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Progressive Aphasia Associated With
    Saracino D; Ferrieux S; Noguès-Lassiaille M; Houot M; Funkiewiez A; Sellami L; Deramecourt V; Pasquier F; Couratier P; Pariente J; Géraudie A; Epelbaum S; Wallon D; Hannequin D; Martinaud O; Clot F; Camuzat A; Bottani S; Rinaldi D; Auriacombe S; Sarazin M; Didic M; Boutoleau-Bretonnière C; Thauvin-Robinet C; Lagarde J; Roué-Jagot C; Sellal F; Gabelle A; Etcharry-Bouyx F; Morin A; Coppola C; Levy R; Dubois B; Brice A; Colliot O; Gorno-Tempini ML; Teichmann M; Migliaccio R; Le Ber I;
    Neurology; 2021 Jul; 97(1):e88-e102. PubMed ID: 33980708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging.
    Leyton CE; Villemagne VL; Savage S; Pike KE; Ballard KJ; Piguet O; Burrell JR; Rowe CC; Hodges JR
    Brain; 2011 Oct; 134(Pt 10):3030-43. PubMed ID: 21908392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristic in Primary Progressive Aphasia in Relation to Alzheimer's Disease Biomarkers.
    Kang SH; Cho H; Shin J; Kim HR; Noh Y; Kim EJ; Lyoo CH; Jang H; Kim HJ; Koh SB; Na DL; Suh MK; Seo SW
    J Alzheimers Dis; 2021; 84(2):633-645. PubMed ID: 34569949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neural correlates of auditory and visuospatial span in logopenic progressive aphasia and Alzheimer's disease.
    Foxe D; Leyton CE; Hodges JR; Burrell JR; Irish M; Piguet O
    Cortex; 2016 Oct; 83():39-50. PubMed ID: 27474916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia.
    Whitwell JL; Duffy JR; Strand EA; Machulda MM; Senjem ML; Schwarz CG; Reid R; Baker MC; Perkerson RB; Lowe VJ; Rademakers R; Jack CR; Josephs KA
    Brain Lang; 2015 Mar; 142():45-53. PubMed ID: 25658633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
    Rabinovici GD; Jagust WJ; Furst AJ; Ogar JM; Racine CA; Mormino EC; O'Neil JP; Lal RA; Dronkers NF; Miller BL; Gorno-Tempini ML
    Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia.
    Santos-Santos MA; Rabinovici GD; Iaccarino L; Ayakta N; Tammewar G; Lobach I; Henry ML; Hubbard I; Mandelli ML; Spinelli E; Miller ZA; Pressman PS; O'Neil JP; Ghosh P; Lazaris A; Meyer M; Watson C; Yoon SJ; Rosen HJ; Grinberg L; Seeley WW; Miller BL; Jagust WJ; Gorno-Tempini ML
    JAMA Neurol; 2018 Mar; 75(3):342-352. PubMed ID: 29309493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.